维持性血液透析患者对BNT162b2疫苗的长期抗体反应。 - Suppr

Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients.

作者信息

Nacasch Naomi, Erez Daniel, Lishner Michael, Benchetrit Sydney, Rozenberg Ilan, Sarel Erez, Shitrit Pnina, Wand Ori, Cohen-Hagai Keren

机构信息

Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Am J Kidney Dis. 2022 Jan;79(1):137-139. doi: 10.1053/j.ajkd.2021.09.002. Epub 2021 Sep 25.

DOI:10.1053/j.ajkd.2021.09.002

PMID:34571066

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8463099/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87dc/8463099/2c1be735dc03/gr1_lrg.jpg

相似文献

Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients.维持性血液透析患者对BNT162b2疫苗的长期抗体反应。

Am J Kidney Dis. 2022 Jan;79(1):137-139. doi: 10.1053/j.ajkd.2021.09.002. Epub 2021 Sep 25.

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients.维持性血液透析患者对BNT162b2疫苗的抗体反应。

Kidney Int. 2021 Jun;99(6):1490-1492. doi: 10.1016/j.kint.2021.04.009. Epub 2021 Apr 20.

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。

Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.

Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis.血液透析患者对两种不同的 mRNA COVID-19 疫苗的抗体反应比较。

J Nephrol. 2022 Jan;35(1):143-151. doi: 10.1007/s40620-021-01195-8. Epub 2022 Jan 3.

Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients-A prospective observational study.接受辉瑞 BNT162b2 疫苗的血液透析患者的反应和结局：一项前瞻性观察研究。

Hemodial Int. 2022 Apr;26(2):216-222. doi: 10.1111/hdi.13005. Epub 2022 Jan 5.

Antibody response in BNT162b2 mRNA-vaccinated dialysis patients and those with coronavirus disease 2019: Long-term follow-up.BNT162b2 mRNA疫苗接种的透析患者和2019冠状病毒病患者的抗体反应：长期随访

Hemodial Int. 2022 Apr;26(2):281-283. doi: 10.1111/hdi.12997. Epub 2021 Dec 22.

Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.血液透析患者中 BNT162b2 和 mRNA-1273 SARS-CoV-2 疫苗的真实世界有效性和免疫原性。

J Am Soc Nephrol. 2022 Jan;33(1):49-57. doi: 10.1681/ASN.2021060778. Epub 2021 Nov 17.

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.评估接受血液透析患者对 BNT162b2 疫苗的 SARS-CoV-2 抗体反应。

JAMA Netw Open. 2021 Sep 1;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622.

Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.mRNA 疫苗 BNT162b2 与腺病毒载体疫苗 Ad26.COV2.S 预防透析患者 COVID-19 的效果比较。

J Am Soc Nephrol. 2022 Apr;33(4):688-697. doi: 10.1681/ASN.2021101395. Epub 2022 Feb 8.

Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.血液透析患者对 BNT162b2 COVID-19 疫苗第三剂的体液反应。

Nephron. 2023;147(3-4):185-192. doi: 10.1159/000525519. Epub 2022 Jul 27.

引用本文的文献

Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients.血液透析患者接种mRNA-BNT162b2疫苗双剂后6个月体液免疫反应减弱

Acta Med Litu. 2023;30(1):26-38. doi: 10.15388/Amed.2023.30.1.3. Epub 2023 Jan 24.

Clinical efficacy of the fourth dose of the BNT162b2 vaccine in maintenance dialysis patients.第四剂 BNT162b2 疫苗在维持性透析患者中的临床疗效。

J Nephrol. 2023 Sep;36(7):1957-1964. doi: 10.1007/s40620-023-01667-z. Epub 2023 Jun 16.

Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study.印度尼西亚日惹地区接受血液透析的终末期肾病患者中 COVID-19 BNT162b2 加强疫苗的免疫原性和安全性：一项队列前瞻性研究。

BMC Nephrol. 2023 May 30;24(1):151. doi: 10.1186/s12882-023-03218-x.

Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients.维持性血液透析患者对乙型肝炎和新冠病毒疫苗的体液免疫反应

Vaccines (Basel). 2022 Oct 7;10(10):1670. doi: 10.3390/vaccines10101670.

Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France.辉瑞/BioNTech BNT162b2 新冠疫苗接种三剂后的反应：法国血液透析患者队列的回顾性研究。

BMC Nephrol. 2022 May 18;23(1):189. doi: 10.1186/s12882-022-02751-5.

Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients.血液透析患者接种新型冠状病毒 2 型疫苗后短期和长期抗体反应减弱。

Vaccines (Basel). 2022 Apr 13;10(4):605. doi: 10.3390/vaccines10040605.

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance.新冠病毒Delta和Omicron变异株主导期间，血液透析患者接种新冠疫苗后的体液反应及突破性感染情况

Vaccines (Basel). 2022 Mar 24;10(4):498. doi: 10.3390/vaccines10040498.

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）mRNA疫苗在血液透析患者中诱导的细胞免疫和体液免疫

Biomedicines. 2022 Mar 9;10(3):636. doi: 10.3390/biomedicines10030636.

Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients.接种疫苗的维持性血液透析患者中体液免疫反应和 SARS-CoV-2 B.1.617.2 变异株突破性感染。

J Nephrol. 2022 Jun;35(5):1479-1487. doi: 10.1007/s40620-022-01245-9. Epub 2022 Feb 17.

本文引用的文献

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。

N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.

Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗，抗体作为一种保护相关因素的证据。

Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.血液透析患者接种 mRNA-1273 和 BNT162b2 新冠病毒疫苗的体液和细胞免疫反应。

Am J Kidney Dis. 2021 Oct;78(4):571-581. doi: 10.1053/j.ajkd.2021.06.002. Epub 2021 Jun 24.

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.接受透析治疗的患者对新冠疫苗接种的抗体反应。

J Am Soc Nephrol. 2021 Oct;32(10):2435-2438. doi: 10.1681/ASN.2021050611. Epub 2021 Jun 11.

Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.COVID-19 疫苗接种后血液透析患者的早期体液反应。

Clin J Am Soc Nephrol. 2021 Jul;16(7):1073-1082. doi: 10.2215/CJN.03700321. Epub 2021 May 24.

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。

Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.

Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.接受透析治疗的患者中 SARS-CoV-2 受体结合域抗体的连续反应。

Ann Intern Med. 2021 Aug;174(8):1073-1080. doi: 10.7326/M21-0256. Epub 2021 May 18.

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.血液透析患者接种BNT162b2（辉瑞-生物科技公司）对SARS-CoV-2疫苗的体液免疫反应

Vaccines (Basel). 2021 Apr 8;9(4):360. doi: 10.3390/vaccines9040360.

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients.维持性血液透析患者对BNT162b2疫苗的抗体反应。

Kidney Int. 2021 Jun;99(6):1490-1492. doi: 10.1016/j.kint.2021.04.009. Epub 2021 Apr 20.

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.接受维持性血液透析患者对辉瑞 BNT162b2 疫苗的体液反应。

Clin J Am Soc Nephrol. 2021 Jul;16(7):1037-1042. doi: 10.2215/CJN.03500321. Epub 2021 Apr 6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献